An Isocyanide-Based Multicomponent Reaction: New Route for Synthesis of
Isoxazolinedione Derivatives
Month 2013
Scheme 2
3
DRX-300 Avance instrument with CDCl3 and C3D6O as solvent
and tetramethylsilane (TMS) as internal standard. Meldrum's acid
and isocyanides were obtained from fluka (Buches, Switzerland)
and used without further purification. Alkylidene Meldrum's acids
were prepared according to reported procedures [6,8,10]. Oximes
were obtained according to a classic procedure.
CH), 3.73 (m, 1H, CH), 5.56 (d, 1H, J = 8.1, NH), 7.59 (d, 1H,
3J = 8.1, NH). 13C NMR (75.47 MHZ, CD6CO) δ ppm 23.8,
24.4, 24.9, 25.3, 25.3, 25.7, 26.0, 29.7, 32.6, 32.7, 32.8, 32.9,
35.6, 35.8, 47.5, 49.3, 50.0, 76.0, 165.0, 167.8, 169.7, 174.7. MS
(ESI): m/z (%) = 461 (11, M+), 336 (71), 268 (31), 114 (55), 111
(51), 98 (100), 83 (46), 67 (52), 55 (81), 41 (56). Anal.calcd. for
C25H39N3O5 (461.59): C, 65.05; H, 8.52; N, 9.10% found: C,
64.95; H, 8.68; N, 9.05%.
General procedure for the synthesis of 4a-4f. Exemplified for
N1-cyclohexyl-1-[4-{1-[(cyclohexylamino)carbonyl]cyclo-
pentyl}-3,5-dihydro-2(3H)-isoxazolyl]-1-cyclohexanecarbox-
N1-Cyclohexyl-2-[2-[2-(cyclohexylamino)-1,1-dimethyl-2-
oxoethyl]-3,5-dioxodihydro-4(3H)-isoxazolyl]-2-methylpropana-
mide (4c). White powder; mp 189–191°C; yield: 51%. IR (KBr)
υ cm−1 3393, 3337 (NH), 1812, 1783, 1704, 1640 (C O), 1530 (NH
bending). H NMR (300.1 MHz, CD6CO) δ ppm 1.15–1.90 (m,
20H, 10 CH2), 1.46, 1.61, 1.64 and 1.72 (4s, 12H, 4 CH3), 2.87
amide (4a).
To a magnetically stirred solution of 2 mmol
(0.42 gr) of cyclopentylidene Meldrum's acid and 2 mmol
(0.226 gr) of cyclohexanone oxime in 10 mL of CH2Cl2, added
dropwise solution of 4 mmol (0.484 mL) cyclohexyl isocyanide
in CH2Cl2 during 10 min. The reaction mixture was allowed to
stir for 48 h at room temperature. The solvent was removed
under reduced pressure, and the residue was purified by silica
gel (Merck 230-240 mesh) column chromatography using
hexane–ethyl acetate 4:1 mixture as eluent. The solvent was
removed and the product was obtained as follows:
1
3
(s, 1H, CH), 3.73 (m, 1H, CH), 5.44 (d, 1H, J = 7.8, NH), 7.38
(d, 1H, J = 7.8, NH). 13C NMR (75.47 MHZ, CD6CO) δ ppm
3
24.7, 24.8, 24.9, 25.3, 25.4, 25.7, 26.0, 32.6, 32.7, 32.9, 47.5,
49.1, 49.3, 50.0, 66.3, 165.3, 167.8, 170.6, 174.6. MS (ESI): m/z
(%) = 435 (56, M+), 309 (27), 236 (100), 225 (10), 83 (80), 55
(74). Anal.calcd. for C23H37N3O5 (435.56): C, 63.42; H, 8.56; N,
9.65% found: C, 63.31; H, 8.62; N, 9.59%.
N1-Cyclohexyl-1-[4-{1-[(cyclohexylamino)carbonyl]cyclopen-
tyl}-3,5-dioxodihydro-2(3H)-isoxazolyl]-1-cyclohexanecarboxa-
N1-Cyclohexyl-1-[4-{1-[(cyclohexylamino)carbonyl]cyclopen-
tyl}-3,5-dioxodihydro-2(3H)-isoxazolyl]-1-cyclopentanecarboxa-
mide (4d). White powder; mp 169–171°C; yield: 56%. IR (KBr)
υ cm−1 3327 (N H), 1809, 1720, 1645, 1630 (C O), 1539 (N H
mide (4a).
White powder; mp 184–186°C; yield: 58%. IR
(KBr) υ cm−1 3326 (NH), 1806, 1721, 1643, 1625 (C O), 1538
(NH bending). 1H NMR (300.1 MHz, CD6CO) δ ppm 1.29–
2.79 (m, 38H, 19 CH2), 3.03 (s, 1H, CH), 3.75 (m, 1H, CH),
5.32 (d, 1H, 3J = 8.0, NH), 7.62 (d, 1H, 3J = 8.0, NH). 13C
NMR (75.47 MHz, CD6CO) δ ppm 21.8, 22.3, 24.7, 24.8, 25.4,
25.4, 25.6, 25.7, 31.4, 31.8, 32.6, 32.8, 32.8, 32.9, 35.8, 36.7,
47.7, 49.1, 49.3, 57.4, 70.6, 76.6, 77.0, 77.4, 165.6, 168.5,
170.1, 175.6. MS (ESI): m/z (%) = 501 (4, M+), 375 (80), 279
(41), 262 (87) 248 (80), 194 (25), 180 (50), 154 (64), 114 (53),
109 (53), 98 (100), 96 (81), 83 (53), 67 (52), 56 (71), 55 (81),
41 (59). Anal.calcd. for C28H43N3O5(501.66): C, 67.04; H,
8.64; N, 8.38% found: C, 66.90; H, 8.80; N, 8.34%.
1
bending). H NMR (300.1 MHz, CD6CO) δ ppm 1.26–2.60 (m,
36H, 18 CH2), 2.954 (s, 1H, CH), 3.749 (m, 1H, CH), 5.33 (d,
1H, J = 7.8, NH), 7.64 (d, 1H, J = 7.8, NH). 13C NMR (75.47
MHZ, CD6CO) δ ppm 23.8, 24.4, 24.8, 25.4, 25.5, 25.7, 32.6,
32.8, 32.8, 32.9, 35.7, 35.8, 36.6, 47.8, 49.2, 57.7, 76.0, 165.3,
168.5, 169.7, 175.5. MS (ESI): m/z (%) = 487 (10, M+), 362
(73), 347 (44), 154 (24), 128 (45), 114 (31), 98 (100), 83 (58),
55 (36). Anal.calcd. for C27H41N3O5 (487.63): C, 66.50; H,
8.47; N, 8.62% found: C, 66.43; H, 8.54; N, 8.57%.
3
3
N1-Cyclohexyl-1-[4-[2-(cyclohexylamino)-1,1-dimethyl-2-
oxoethyl]-3,5-dioxodihydro-2(3H)-isoxazolyl]-1-cyclohexanecar-
boxamide (4b). White powder; mp 174–176°C; yield: 46%. IR
(KBr) υ cm−1 3369 (NH), 1817, 1730, 1650, 1645 (C O), 1549
N1-Cyclohexyl-1-[4-[2-(cyclohexylamino)1,1-dimethyl-2-
oxoethyl]-3,5-dioxodihydro-2(3H)-isoxazolyl]-1-cyclohexanecar-
boxamide (4e). White powder; mp 150°C; yield: 43%. IR (KBr)
υ cm−1 3343 (N H), 1821, 1746, 1723, 1637 (C O), 1555 (N H
1
1
(NH bending). H NMR (300.1 MHz, CD6CO) δ ppm 1.17–2.31
bending). H NMR (300.1 MHz, CD6CO) δ ppm 1.16–2.67 (m,
(m, 28H, 14 CH2), 1.61 and 1.64 (2s, 6H, 2 CH3), 2.91 (s, 1 H,
30H, 15 CH2), 1.62 and 1.66 (2s, 6H, 2 CH3), 2.99 (s, 1H, CH),
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet